Addressing the global health challenge of type 2 diabetes requires safer therapeutic options beyond conventional treatments with known limitations. This systematic evaluation explores the potential of β-glucans from diverse sources in diabetes management. By integrating existing research on gut microbiota modulation and short-chain fatty acid metabolism, we elucidate the mechanisms through which β-glucans alleviate diabetes and its complications, including neurodegeneration, cardiovascular impairment, and renal fibrosis. The analysis reveals how β-glucans remodel microbial metabolic networks through short-chain fatty acid production and bile acid cycle regulation, modulate energy metabolism pathways, and disrupt oxidative stress-inflammatory crosstalk. Based on comprehensive safety assessments, we establish scientific intake guidelines while investigating β-glucans' structural stability and functional retention during food processing as well as their targeting efficiency and controlled-release properties as nanocarriers for drug delivery. This work provides a theoretical foundation for the dual application of β-glucans in precision nutrition and intelligent drug development for diabetes management.
β-Glucans in Food Systems: Balancing Health, Safety, and Diabetes Prevention.
Xuefeng Liu,Yuqin Feng,Yating Song,Jiangxue Wang,Yuqing Duan,Guishan Liu
Published 2025 in Journal of Agricultural and Food Chemistry
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Journal of Agricultural and Food Chemistry
- Publication date
2025-11-10
- Fields of study
Agricultural and Food Sciences, Medicine, Environmental Science
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
- No citing papers are available for this paper.
Showing 0-0 of 0 citing papers · Page 1 of 1